More news on: Prof. Erika Lietzan

Professor Lietzan Publishes on Regulation of Biosimilars and Biotechnology Drugs, Devices

May 27th, 2015

Erika Lietzan

Professor Erika Lietzan is the editor of a recently-published book on premarket and postmarket regulation of biotechnology drugs and devices. The book, Medical Biotechnology: Premarket and Postmarket Regulation, contains a chapter co-authored by Professor Lietzan that focuses on FDA regulation of drug and device clinical trials.

She also recently published a chapter on biosimilars in Food and Drug Law and Regulation, 3rd Edition. She is one of the experts on biosimilar biological products and represented the innovative industry in the legislative negotiations leading to enactment of the statute in question in 2010. The chapter was co-authored with an attorney from AbbVie and one from Covington & Burling, LLP.

Professor Lietzan is chair of the Life Sciences Division of the American Bar Association Section of Science and Technology Law.

 

Tags: , , , ,